Adalimumab vs Erlotinib

## Adalimumab vs Erlotinib: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Erlotinib**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Erlotinib — 36 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Erlotinib — C22H23N3O4.

**Molecular Weight**: Adalimumab — N/A; Erlotinib — 393.4380 g/mol.

**Type**: Adalimumab — Antibody; Erlotinib — Small molecule.